Recall underway


recall regulatory
Recall notice issued for several Zantac brands following contamination fear The TGA is advising consumers and health professionals that several ranitidine-containing products have been removed from the Australian market due to contamination with an impurity called N‑nitrosodimethylamine (NDMA). "Ranitidine tablets and oral liquids are now in short supply as a number of commonly-used brands have been

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Self-care: 14 professional responsibilities
Next Pain and opioids and the bigger picture